WHO 'strongly advises against' use of two COVID treatments COVID19
GSK and partner Vir Biotechnology’s sotrovimab – which has generated billions in sales and became one of the British drugmaker’s top sellers last year – was pulled off the U.S. market by the U.S. Food and Drug Administration in April.
“Now WHO has issued this recommendation, it will be interesting to see how many other countries align with it,” she said.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WHO 'strongly advises against' use of two COVID treatmentsTwo COVID\u002D19 antibody therapies are no longer recommended by the World Health Organization.
Read more »
End of COVID pandemic is 'in sight', WHO chief saysThe world has never been in a better position to end the COVID\u002D19 pandemic, the head of the World Health Organization said on Wednesday, his most optimistic…
Read more »
End of COVID-19 pandemic is in sight: WHO chiefThe world has never been in a better position to end the COVID\u002D19 pandemic, the head of the World Health Organization said on Wednesday.
Read more »
End of COVID-19 pandemic is in sight: WHO chiefThe world has never been in a better position to end the COVID\u002D19 pandemic, the head of the World Health Organization said on Wednesday.
Read more »
End of COVID-19 pandemic is in sight: WHO chiefThe world has never been in a better position to end the COVID\u002D19 pandemic, the head of the World Health Organization said on Wednesday.
Read more »